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Two orders of magnitude matrix-assisted laser desorption/ionization (MALDI) signal enhance-
ment of phosphopeptides has been achieved by picolinamidination of N-terminal amine group
and -amine group of lysine residues. Due to the presence of picolinamidination tag at the
N-terminal amine of peptides, MS/MS spectra with a strong b-ion series was obtained, which
greatly facilitated sequencing and identification of the phosphorylation site. Phosphorylation site
of a phosphopeptide could be identified fromMALDI TOF/TOF spectrum obtained from a tryptic
or a chymotryptic phosphopeptide, whichwas not even detected in the positive ionmode, without
signal enhancement by picolinamidination, due to the negative charge of the phosphate group in
the presence of other peptides. (J Am Soc Mass Spectrom 2009, 20, 1751–1758) © 2009 American
Society for Mass SpectrometryIdentification of phosphoprotein and its phosphory-lation site is an important part of proteomics re-search. Matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometric analy-
sis of phosphopeptides is a key step in investigation of
a phosphoprotein [1–6]. Yet, it is limited by the low
concentration of phosphoproteins in cells and the low
ionization efficiency of phosphopeptides due to the
negatively charged phosphate group [7, 8]. Therefore,
orders of magnitude increase in the mass spectrometric
signal intensity could be critical in the analysis of low
abundance phosphopeptides.
Given the capability of the mass spectrometer avail-
able, two different approaches are conceivable for de-
tection of low abundance phosphopeptides. A straight-
forward approach is enrichment. Immobilized metal
ion affinity chromatography (IMAC) is the most widely
used technique for enrichment of phosphopeptides
[9–14]. Recently, enrichment methods using metal ox-
ide instead of metal ion have been developed [15–19].
Affinity separation after binding specific functional
groups via -elimination/Michael addition has also
been used [20–25].
Esterification of acidic peptides could reduce their
ionization efficiency in the negative mode and thus
make selective detection of phosphopeptides possible
[6]. In a more direct approach, a highly basic moiety
could be incorporated to the phosphopeptide by
-elimination/Michael addition to replace the negative
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doi:10.1016/j.jasms.2009.05.016charge of the phosphate group and to enhance the
MALDI signal in the positive ion mode [26–30]. Cou-
marin tagging of amine could enhance the MALDI
signal of phosphopeptides 30- to 40-fold [4]. Addi-
tives in the matrix solution were also used to improve
detection of phosphopeptides without enrichment and
derivatization [3, 31].
A cumulative effect of peptide enrichment and signal
enhancement would be desirable, since most phos-
phopeptides of interest exist in cells at low concentra-
tion. If the concentration of a certain phosphopeptide is
100 times lower than the detection limit of the available
mass spectrometer, a 10-fold enrichment will not be
sufficient. However, another 10-fold signal enhance-
ment by chemical derivatization could bring the phos-
phopeptide signal above the noise level.
Recently, we showed that the MALDI signal of a
peptide could be enhanced over 20-fold by picolina-
midination [32]. Ethyl picolinimidate reacts with the
N-terminal amino group as well as the -amino group
of lysine residues. The picolinamidine group is strongly
basic and thus significantly increases the ionization
efficiency of the modified peptide. Picolinamidination
would be quite useful if the added basicity could
counteract the suppressed ionization efficiency of a
phosphopeptide in the positive ion mode. In this paper,
we show that over 100-fold enhancement of the MALDI
signal from phosphopeptides and other acidic peptides
could be achieved by picolinamidination. The charac-
teristic fragmentation pattern of picolinamidinated
peptides with enhanced signal intensity significantly
improved tandem mass spectrometric sequencing
and identification of phosphorylation site of synthetic
phosphopeptides.
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Chemicals
Picolinamide and -cyano-4-hydroxycinnamic acid (CHCA)
were obtained fromAldrich (MilwaukeeWI, USA). Peptides
(DRVYIHPF, ASHLGLAR, DAEFRHDSGYQVHHQK)
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
PyBOP, Fmoc-Glu(OtBu)-OPfp, Fmoc-Asp(OtBu)-OH,
Fmoc-Ser(PO-(OBzl)OH)-OH, Fmoc-Thr(PO-(OBzl)OH)-
OH, and Fmoc-Tyr(PO-(OBzl)OH)-OH used in peptide
synthesis were from Novabiochem (San Diego, CA,
USA). Nitrilotriacetic acid (NTA), trifluoroacetic acid
(TFA),N,N-diisopropylethylamine, piperidine, methylene
chloride, acetonitrile, triethanol amine (TEA) dimethyl
sulfoxide, N,N-dimethylformamide, and triisopropylsi-
lane were from Sigma-Aldrich. Triethyloxonium tet-
rafluoroborate was from TCI (Tokyo, Japan).
Synthesis of Ethyl Picolinimidate Tetrafluoroborate
Ethyl picolinimidate (EPI) tetrafluoroborate was syn-
thesized as reported [33]. Forty mg picolinamide (0.33
mmol) was dissolved in 670 L of anhydrous methyl-
ene chloride and 330 L of 1 M solution of triethyloxo-
nium tetrafluoroborate in methylene chloride (0.33
mmol) was added. The mixture was vortex-mixed over-
night at room temperature until pink color from the
initial reaction completely disappeared. The precipitate
was removed by centrifugation, and methylene chloride
from the supernatant was removed using a vacuum
centrifuge to get the desired product as white precipi-
tate. EPI could be used for as long as 30 d if kept away
from moisture, which hydrolyzes EPI.
Synthesis of Peptides
Some peptides and phosphopeptides (GDpTKAVEK,
AEQpSLKDVNK, RESGpTNAY, AKGQpYVDY, RpYKVF,
RYKVF, WDEGDF, AEDDVEDY, AENDVGDK) were
synthesized by the solid-phase method of Merrifield.
Peptides synthesized were purified by reveres-phase
HPLC. After checking the molecular weight and purity
by MALDI MS, the peptide was freeze-dried after
evaporation of the solvent and stored in a freezer.
Picolinamidination of Peptides and MALDI
Sample Preparation
A preliminary test showed that picolinamidination of
phosphopeptide is slower than that of normal peptides.
Therefore, the EPI concentration and reaction time were
increased over the reported values [32]. Typically, 10L of
10Mphosphopeptide inwater wasmixedwith the same
volume of 100 mM ethyl picolinimidate tetrafluoroborate
(EPI) (23.7 mg/mL, 10,000-fold molar excess) in 500 mM
TEA buffer (pH 8.0). Picolinamidination was allowed to
proceed overnight at room temperature (Scheme 1) and
terminated by adding 5 L 1.0% TFA to 5 L of thereaction mixture. To remove excess reagents for MALDI
analysis, 5 L of the final mixture was loaded on ZipTip
C18 (Millipore, Bedford, MA, USA) and eluted with 5
L matrix solution. The matrix solution was made by
dissolving 10 mg CHCA in 1 mL mixture of acetonitrile
and water, 1:1, containing 0.1% TFA and 7 mM NTA
used to suppress matrix clusters [34]. The concentration
of picolinamidinated peptide loaded on the MALDI
plate was estimated to be 2.0–2.5 M. For acidic pep-
tides, 5000-fold excess EPI in 250 mM TEA buffer was
used and picolinamidination reaction was allowed to
proceed for 1–2 h at room temperature.
MALDI MS Analysis
One L of the picolinamidinated peptide solution in the
matrix solution was loaded on the MTP 384 polished
steel plate. Mass spectra were obtained in positive ion
mode using Auto Flex II MALDI-TOF/TOF mass spec-
trometer (Bruker Daltonics, Bremen, Germany) equipped
with a 337 nm N2 laser. Typically, signals from 100
shots were added. MALDI MS/MS data were obtained
using laser-induced dissociation mode and LIFT tech-
nique. Collision-induced dissociation mode was also
used for phosphopeptides.
Results and Discussion
Signal Enhancement of Acidic Peptides by
Picolinamidination
Signal enhancement by picolinamidination was first
tested using peptides with acidic amino acid residues,
which are known to suppress signal intensity in the
positive ion mode. Thus, peptides were synthesized
with several aspartic acid and glutamic acid residues so
that the final pI of the peptide should be less than 4.
Modification by one picolinamidination increases m/z
Scheme 1. Reaction of ethyl picolinimidate with the amine
group of a phosphopeptide.by 104.04.
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residues (theoretical pI 2.71) was complete in 2 h; 10:1
mixture with equal volume of the original peptide (20
M) and the picolinamidinated peptide (2 M) showed a
small peak of the original peptide with S/N of 37 and a
much stronger peak of the picolinamidinated peptide
with S/N of 190 (Figure 1a). The result shows a 50-fold
signal enhancement.
Signal enhancement of AENDVGDK with three acidic
residues (theoretical pI 3.74) was more pronounced. The
MALDI spectrum from an equimolar (2 M) mixture of
the original peptide and the picolinamidinated peptide
showed the picolinamidinated peptide peak only (m/z
1055.5, result not shown). When 40 M solution of the
original peptide and 2 M solution of the picolinamidi-
nated peptide were mixed in equal volume, the picoli-
namidinated peptide peak was 12 times stronger than
the original peptide (m/z 847.4 peak) indicating about
240-fold signal enhancement (Figure 1b).
The signal enhancement was confirmed at a limiting
concentration of the original peptide; 2.0 M solution of
AEDDVEDY showed no peak (Figure 2a). After enrich-
ment using ZipTip, the original peptide and its sodium
adduct were observed with S/N of 5 and 18, respec-
tively (Figure 2b). To get the mass spectrum in Figure
2b, 8 L of 2.0 M peptide solution was mixed with 2
uL of 250 mM TEA buffer. The mixture was loaded on
ZipTip and eluted with 3 L of the matrix solution.
Thus the peaks in Figure 2b result from about 5 M
peptide in the solution loaded on the sample plate.
When the peptide was treated similarly except that 40
mM EPI in 250 mM TEA buffer was used for picolina-
midination, a strong peak of picolinamidinated peptide
Figure 1. MALDI spectra obtained from a mixt
peptide in 10:1 (a), (c), (d), and 20:1 M ratio. (a) A
(d) GDpTKAVEK. PA: picolinamidinated.was observed at m/z 1059.4 with S/N of 1140 (Figure
2c). The signal enhancement was about 230-fold relative
to the peptide peak in Figure 2b and 60-fold relative to
the sodium adduct. Generally, over 50-fold signal en-
hancement was obtained from acidic peptides.
Signal Enhancement of Phosphopeptides by
Picolinamidination
Picolinamidination of AEQpSLKDVNK (MW 1211.6)
and GDpTKAVEK (MW 927.4) with three amino groups
(N-terminal plus 2 lysines) were expected to increase
m/z by 312.1 to 1523.7 and 1239.5, respectively. Both
MALDI spectra in Figure 1c and d obtained from a
mixture with equal volume of unmodified (20 M) and
picolinamidinated peptide (2 M) at 10:1 M ratio show
triply picolinamidinated peptide peaks as dominant
peaks. Smaller di-picolinamidinated peptides were ob-
served at m/z 1419.7 and 1135.5. Loss of the phosphate
group (79.97 Da) was also observed. It might come
partly from the dephosphorylated peptide impurity
even though the peptide was purified by HPLC after
synthesis. LC/MS analysis of the peptides before pico-
linamidination reaction showed 1%2% of the dephos-
phorylated peptides (79.97 Da), and this percentage
did not change significantly after picolinamidination as
measured by LC/MS (result not shown). The relatively
high intensity of the dephosphorylated peptide peaks in
Figure 1c and d might reflect the presence of dephos-
phorylated peptide impurity in the original sample
and/or in the derivatization reaction products and
laser-induced dissociation in this case even though
f the original peptide and the picolinamidinated
VEDY, (b) AENDVGDK, (c) AEQpSLKDVNK,ure o
EDD
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phosphopeptides.
The original peptides present in 10-fold excess were
much lower in signal intensity than the picolinamidi-
nated peptides. The signal intensity of triply picolina-
midinated AEQpSLKDVNK (m/z 1523.7) was 10 times
higher than that of the original peptide present in
tenfold excess (Figure 1c). The result shows that the
MALDI ionization yield of phosphopeptide was en-
hanced about 100-fold upon picolinamidination. A sim-
ilar or even greater signal enhancement (150-fold) was
observed from GDpTKAVEK (Figure 1d).
The signal enhancement was again confirmed at a limit-
ing concentration of a phosphopeptide AKGQpYVDY.
The original phosphopeptide was not detected at 0.5
M concentration (Figure 2d). After 3-fold concentra-
tion with ZipTip, a small peak with S/N ratio of 4 was
observed at m/z 1023.4 (Figure 2e). After reaction, singly
picolinamidinated phosphopeptide peak (m/z 1127.5)
with S/N ratio of 410 was obtained (Figure 2f). The
result again shows about 100-fold signal enhancement.
GDpTKAVEK also showed over 100-fold signal enhance-
ment (result not shown). These results show that at least
100-fold signal enhancement could be achieved by picoli-
Figure 2. MALDI spectra from acidic peptide A
(d)–(f) at limiting concentration. (a) 2.0 M, witho
with ZipTip to 5.3 M, without picolinamidination
m/z 977.40, (c) 5.3 M, with picolinamidination, sh
(d) 0.5 M, without picolinamidination, showing
picolinamidination, showing original peptide atm/
singly picolinamidinated peptide at m/z 1127.46.namidination from a variety of phosphopeptides.Signal Enhancement in a Peptide Mixture
To demonstrate signal enhancement of phosphopep-
tide in a peptide mixture, a solution containing five syn-
thetic tryptic peptides (GDpTKAVEK, AEQpSLKDVNK,
AENDVGDK, ASHLGLAR, DAEFRHDSGYQVHHQK)
at 2 M concentration each was used. The MALDI
spectrum in Figure 3a from the mixture without picoli-
namidination showed the two arginine(R)-containing
peptides (ASHLGLAR and DAEFRHDSGYQVHHQK
atm/z 824.5, S/N 270 and 1953.9, S/N 840, respectively),
but not the two phosphopeptides (GDpTKAVEK,
AEQpSLKDVNK) and the acidic peptide without R
(AENDVGDK). If we assume that AENDVGDK and
GDpTKAVEK were just under the noise (S/N  1), we
can say that their signal is 270 times weaker than the
ASHLGLAR signal.
After picolinamidination, both phosphopeptides
(m/z 1239.9, S/N 360 and 1524.3, S/N 58) and the
acidic peptide (m/z 1055.7, S/N 460) were observed
(Figure 3b) indicating a significant enhancement of
the signal intensity. The DAEFRHDSGYQVHHQK
signal became much weaker after picolinamidination
probably due to suppression by other enhanced
VEDY (a)–(c) and phosphopeptide AKGQpYVDY
olinamidination, showing no signal, (b) enriched
wing peptide at m/z 955.35 and sodium adduct at
g singly picolinamidinated peptide at m/z 1059.39,
nal, (e) enriched with ZipTip to 1.3 M, without
3.42, (f) 1.3 M, with picolinamidination, showingEDD
ut pic
, sho
owin
no sig
z 102peaks.
. Aste
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thetic chymotryptic peptide mixture (RESGpTNAY,
AKGQpYVDY, RpYKVF, RYKVF,WDEGDF, AEDDVEDY,
DRVYIHPF; 1 M each). Of the seven peptides, only
three were observed. All three had R and one was a
phosphopeptide. After picolinamidination, the two
phosphopeptides (RESGpTNAY and AKGQpYVDY),
and the two acidic peptides (WDEGDF andAEDDVEDY),
not detected before were observed (Figure 3d). The
signal RpYKVF dephosphorylated seems to be added
up to the signal intensity of RYKVF, before and after
picolinamidination. Probably picolinamidinated RYKVF
and DRVYIHPF were suppressed by picolinamidinated
RpYKVF.
It appears from the results presented above that the
effect of introducing positive charge by picolinamidina-
tion is most pronounced with phosphopeptides. Ini-
tially, we reported 20- to 35-fold signal enhancement
using ordinary peptides [32]. Signal enhancement of
phosphopeptides is an order of magnitude greater.
Pashkova et al. reported that coumarin tag increases
MALDI signal of ordinary peptides 2- to 10-fold, while
phosphopeptide signal is increased 30- to 40-fold [4].
They attributed the signal enhancement to an increased
hydrophobic interaction between coumarin and the
CHCA matrix, which would be more pronounced in
hydrophilic phosphopeptide. Signal enhancement by
picolinamidination is about an order of magnitude
greater than by coumarin tag probably due to the
combined effect of the increased basicity upon picoli-
namidination and increased interaction with the matrix
Figure 3. MALDI spectra from a mixture of fiv
synthetic chymotryptic peptides (c), (d), withou
(b), (d), and a mixture of at 0.25 M concentratio
picolinamidination, (d) with picolinamidinationin terms of co-crystallization and energy transfer.Sequencing Picolinamidinated Tryptic Peptide by
MS/MS
Having demonstrated that acidic peptide and phos-
phopeptide signal could be significantly elevated so
that peptides not detected at all yield a strong signal
upon picolinamidination, we attempted to sequence
these peptides by tandem mass spectrometry. The m/z
1055.7 peak from the acidic peptide, AENDVGDK, in
Figure 1b was selected. Figure 4a shows TOF/TOF
spectrum from the m/z 1055.67 peak. All of the fragment
ions in the y-series (y1–y7) and b-series (b1–b7) were
observed. The correct sequence was readily determined
from these ions.
The y7 peak was the strongest. Beardsley and Reilly
and coworkers reported that peptide bond of the N-
terminal amino acid of an amidinated peptide is pref-
erentially dissociated in the MS/MS process, and, there-
fore, b1 and yn–1 ions are the most abundant among
fragment ions [35, 36]. In the case of a picolinamidi-
nated tryptic peptide like AENDVGDK, where the
C-terminal lysine residue is picolinamidinated, all of
the y-series ions should have a picolinamidination tag
at the C-terminal and thus would yield a strong signal.
The b-series ions carry a picolinamidination tag at the
N-terminus. Thus, both the y-series and the b-series
ions are observed. This high intensity of all y-series and
the b-series peaks would be very useful in tandem mass
spectrometric sequencing of tryptic peptides following
picolinamidination. Peptides with C-terminal arginine
yield strong signal without picolinamidination. There-
nthetic tryptic peptides (a), (b), and from seven
linamidination (a), (c), with picolinamidination
h upon loading on the sample plate, (c) without
risk indicate site of picolinamidination.e sy
t pico
n eacfore, signal enhancement of peptides with C-terminal
ns.
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peptides with C-terminal arginine in peptide sequenc-
ing as well as in peptide mapping.
It would be highly desirable to be able to identify
the phosphorylation site from a phosphopeptide by
MS/MS experiment. TOF/TOF experiment was per-
formed on the picolinamidinated phosphopeptide,
GDpTKAVEK, in Figure 1d obtained by loading 1 pmol
peptide on the plate. The MS/MS spectrum in Figure 4b
shows that pairs of peaks, phosphorylated and frag-
ments showing a loss of phosphoric acid, are obtained
from the parent peptide, y7 and y6 ions, but not from y5
and lower y-series ions. The result clearly indicates that
the sixth residue from the C-terminus, T, is phosphor-
ylated. Identification of the phosphorylation site by the
MS/MS experiment was possible by the increased ion
yield upon picolinamidination.
Sequencing Picolinamidinated Chymotryptic
Peptide by MS/MS
Chymotryptic peptides do not have C-terminal arginine
or lysine that could be picolinamidinated. Yet, since
only the N-terminal amine group is picolinamidinated,
b-series ion signal should be enhanced while y-series
Figure 4. MALDI TOF/TOF spectrum of pi
showing strong y-series ions, (b) GDpTKAVEK,
y7 and y6, but not from y5 and lower y-series ioion should be suppressed. So, we can easily deduce thesequence information from the MS/MS spectrum show-
ing predominant b-series ions. Figure 5a shows MALDI
TOF/TOF spectrum of picolinamidinated chymotryptic
peptide with five acidic residues, AEDDVEDY; b2
through b7 ions have acidic residues. Yet, due to the
picolinamidination tag at the N-terminus, all b-series
ions were detected and the correct sequence could be
deduced from these ions; y-series ions without the
picolinamidination tag were less intense.
Figure 5b shows MALDI TOF/TOF spectrum of
picolinamidinated phosphopeptide, RESGpTNAY; b-
series ions were predominant over y-series ions, which
were hardly detected. Dephosphorylated peaks were
observed from b6 and b5, but not from b4 and lower
b-series ions. The result clearly shows that the 5th
residue from the N-terminus, T, is the phosphorylation
site. This data illustrate that the picolinamidination
could be useful for chymotryptic peptides as well as for
tryptic peptides.
Conclusions
Picolinamidination of amino groups in peptides dra-
matically enhances MALDI signal intensity of phos-
phopeptides. The signal enhancement could be utilized
amidinated tryptic peptide, (a) AENDVGDK,
ing fragments with loss of phosphoric acid fromcolin
showfor sequencing and phosphorylation site analysis from
b4 a
1757J Am Soc Mass Spectrom 2009, 20, 1751–1758 PHOSPHOPEPTIDE SEQUENCING BY PICOLINAMIDINATION AND MALDI MSeither tryptic or chymotryptic phosphopeptides at lim-
iting concentrations by MALDI TOT-TOF MS. It is
hoped that picolinamidination would help analyze low
concentration phosphopeptides of importance in pro-
teomics either by itself or in combination with enrich-
ment techniques.
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